This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: Chung Ang University Industry Academic Cooperation, Chungbuk National University Industry-Academic Cooperation Foundation, Industry Academic Cooperation Foundation Hallym University. Active years: 2015-2018.
Company Filing History:
2 out of 208 
1 out of 46 
1 out of 21 Years Active: 2015-2018
Title: Yeoun Sook Chun: Innovator in Ocular Therapeutics
Introduction
Yeoun Sook Chun is a prominent inventor based in Seoul, South Korea. She has made significant contributions to the field of ocular therapeutics, particularly in the treatment of glaucoma and corneal endothelial wounds. With a total of 2 patents, her work is paving the way for innovative treatments in ophthalmology.
Latest Patents
One of her latest patents is focused on the use of angiogenin for the treatment of glaucoma. This pharmaceutical composition aims to prevent or treat glaucoma by utilizing angiogenin or its fragments as active ingredients. The invention highlights how angiogenin activates aqueous humor outflow, leading to a reduction in intraocular pressure. This innovative approach could significantly impact glaucoma management.
Another notable patent involves a pharmaceutical composition for treating corneal endothelial wounds, which also includes angiogenin as an effective ingredient. This invention explores a new therapeutic use of angiogenin, which activates the PI3K/Akt/eNOS pathway in ocular corneal endothelium. This activation promotes the migration and proliferation of corneal endothelial cells, which are typically incapable of self-proliferation, thus aiding in the prevention and treatment of corneal endothelial cell wounds.
Career Highlights
Yeoun Sook Chun has worked with esteemed institutions such as Chung Ang University Industry Academic Cooperation and Chungbuk National University Industry-Academic Cooperation Foundation. Her career reflects a strong commitment to advancing research and development in ocular health.
Collaborations
Throughout her career, she has collaborated with notable colleagues, including Sung Wook Wee and Kyoung Woo Kim. These partnerships have contributed to her innovative research and the successful development of her patents.
Conclusion
Yeoun Sook Chun's contributions to ocular therapeutics through her innovative patents demonstrate her dedication to improving eye health. Her work has the potential to transform treatment options for glaucoma and corneal endothelial wounds, making her a significant figure in the field of ophthalmology.